Aaron Bowman joined Purdue in 2018 as head of the School of Health Sciences and has served as interim dean since November ...
Twenty-five years ago, the bestseller “The Tipping Point” turned Malcolm Gladwell into a household name. Describing “the critical mass, the threshold, the boiling point,” Gladwell illustrates ...
Registration is open for faculty to attend the Westwood Lecture Series on Feb. 19. Two leading Purdue researchers will discuss the university’s growing role in the next revolution of ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
The recent settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is a welcome ...
Montana is expected to receive more than $16 million from a legal settlement reached by a coalition of states that sued Purdue Pharma and the family that owns it for their role in stoking the ...
New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis, with the ...
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...
WASHINGTON (AP) — US existing home sales in 2024 tumble to lowest level in nearly 30 years as median price hits an unprecedented $407,500.
WTNH Hartford on MSN22d
Purdue Pharma, owners could pay $7.4 billion in new settlement over toll of OxyContinMembers of the family who own OxyContin maker Purdue Pharma and the company itself agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results